BY WILLIAM SANSUM DIABETES CENTER: A study just released shows that continuous glucose monitoring (CGM) use in pregnancy is beneficial for both mother and baby. A results publication for the JDRF CONCEPTT trial was released this month. William Sansum Diabetes Center’s Dr. Kristin Castorino was the only US investigator on the study. The full study can be found here.
The JDRF-funded study published in the Lancet found that monitoring blood sugar levels continuously during pregnancy via a continuous glucose monitor (CGM) led to significantly better health outcomes for mothers with type 1 diabetes (T1D) and their babies. The results of this randomized trial, held across 31 hospitals in Canada, the United Kingdom, Spain, Ireland, Italy, and the United States, prompted the authors to call for physicians to offer CGM devices to all pregnant women with T1D. (read more)
BY HEALTHDAY: Yi-Ju Tseng, Ph.D., from Boston Children’s Hospital, and colleagues retrospectively analyzed unidentifiable member claims data from 52,544 individuals covered by Aetna who had two physician claims or one hospitalization with a type 2 diabetes diagnosis (2010 to 2015).
The researchers found that of 22,956 patients given second-line treatment, only 8.2 percent had evidence of recommended use of metformin in the prior 60 days, and 28.0 percent had no prior claims evidence of having taken metformin. Only 49.5 percent of patients could have had recommended use. An additional second-line antihyperglycemic medication or insulin was more likely in patients given their initial second-line medication without evidence of recommended use of metformin (P < 0.001). (read more)
BY JANE ROWAN: According to the National Diabetes Statistics Report from the Centers for Disease and Control (CDC), approximately 29.1 million people in the United States have diabetes with 8.1 million of those people being undiagnosed.
Similarly in Texas, approximately 1.8 million adults have diabetes with 440,468 of those being undiagnosed.
In Texas, Hispanic/Latinos are disproportionately burdened by diabetes. For Hispanic/Latino adults over 18 years of age, rates are higher (11 percent) than their White, non-Hispanic counterparts (8.2 percent). Hispanic/Latinos are a growing segment of the US population, with higher rates of diabetes prevalence, mortality, and disease complications compared with whites. (read more)